FY2025 · period end Dec '25 · from the 10-K filed Feb 26, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $16.99B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000105634-26-000085 | Jun 4, 2026 | Jun 4, 2026 | Jun 4, 2026 20:15 UTC | EDGAR |
| 8-K | 0000105634-26-000048 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 12:05 UTC | EDGAR |
| 10-Q | 0000105634-26-000046 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 11:32 UTC | EDGAR |
| 8-K | 0000105634-26-000027 | Feb 26, 2026 | Feb 26, 2026 | Feb 26, 2026 14:33 UTC | EDGAR |
| 10-K | 0000105634-26-000025 | Dec 31, 2025 | Feb 26, 2026 | Feb 26, 2026 12:34 UTC | EDGAR |
| 8-K | 0000105634-25-000082 | Oct 30, 2025 | Oct 30, 2025 | Oct 30, 2025 12:48 UTC | EDGAR |
| 10-Q | 0000105634-25-000078 | Sep 30, 2025 | Oct 30, 2025 | Oct 30, 2025 11:33 UTC | EDGAR |
| 8-K | 0000105634-25-000073 | Oct 27, 2025 | Oct 29, 2025 | Oct 29, 2025 15:40 UTC | EDGAR |
Direct links to SEC EDGAR. EME has additional filings available on the SEC site.
6 numbers EMCOR Group, Inc. later changed — same XBRL tag, both filings linked.
Income (Loss) from Continuing Operations before Income Taxes, Foreign·FY 2012
Major restatementwas$7.5M
Revised up in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q2 2011
Major restatementwas$5M
Revised up in a 10-Q. Any P/OCF built on the original was 20.0% too high.
Net Cash Provided by (Used in) Operating Activities·Q1 2017
Major restatementwas-$5.2M
Revised up in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2013
Major restatementwas$202.7M
Revised up in a 10-K.
Operating Income (Loss)·FY 2013
Major restatementwas$210.3M
Revised up in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q2 2012
Notable restatementwas-$11.6M
Revised up in a 10-Q.
EME is not the only one.
See every restatement we've found across the market — or get an alert the next time EME revises a number.
Restatements are detected by comparing every vintage of a fact across all of EMCOR Group, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows EME's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling EMCOR Group, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on EME yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on EME and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $12.58B |
| $11.08B |
| $9.90B |
| Gross Profit | $3.28B | $2.77B | $2.09B | $1.60B | $1.50B |
|---|
| Operating Income | $1.71B | $1.34B | $0.88B | $0.56B | $0.53B |
|---|
| Net Income | $1.27B | $1.01B | $0.63B | $0.41B | $0.38B |
|---|
| EPS (Diluted) | $28.19 | $21.52 | $13.31 | $8.10 | $7.06 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $9.29B | $7.72B | $6.61B | $5.52B | $5.44B |
| Total Liabilities | $5.62B | $4.78B | $4.14B | $3.55B | $3.19B |
| Stockholders' Equity | $3.67B | $2.94B | $2.47B | $1.97B | $2.25B |
| Cash & Equivalents | $1.11B | $1.34B | $0.79B | $0.46B | $0.82B |
| Total Debt | — | — | $0.00B | $0.23B | $0.25B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.30B | $1.41B | $0.90B | $0.50B | $0.32B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 19.3% | 19.0% | 16.6% | 14.5% | 15.2% |
| Operating Margin | 10.1% | 9.2% | 7.0% | 5.1% | 5.4% |
| Net Margin | 7.5% | 6.9% | 5.0% | 3.7% | 3.9% |
| Return on Equity | 34.6% | 34.3% | 25.6% | 20.6% | 17.0% |
| Return on Assets | 13.7% | 13.1% | 9.6% | 7.4% | 7.0% |
| Debt / Equity | — | — | 0.00× | 0.12× | 0.11× |
